MCM
AUXL

Masters Capital Management’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Masters Capital Management’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-300,000
Closed -$4.99M – 60
2013
Q2 		$4.99M Buy
+300,000
New +$4.79M 0.38% 30

Other funds holding AUXL

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Masters Capital Management's AUXL Position: Q3 2013 in Review

Masters Capital Management sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q3 2013, closing a stake of 300,000 shares — an estimated $4.99M sold.

Masters Capital Management first reported a position in AUXL in Q2 2013 and held it in 1 quarter. The position peaked at $4.99M in Q2 2013. 150 funds tracked by Wall St. Rank hold AUXL as of Q3 2013.

  • Masters Capital Management reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q3 2013 after selling out during the quarter.
  • Masters Capital Management sold 300,000 AUXILIUM PHARAMCEUTICALS INC shares in Q3 2013, an estimated $4.99M.
  • Masters Capital Management first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 1 quarter.
  • Masters Capital Management's AUXILIUM PHARAMCEUTICALS INC position peaked at $4.99M in Q2 2013.
  • 150 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q3 2013.

Based on Masters Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.